Page last updated: 2024-11-05

thiotepa and Incontinentia Pigmenti Achromians

thiotepa has been researched along with Incontinentia Pigmenti Achromians in 8 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"High-dose thiotepa, a polyfunctional alkylating agent used in the treatment of solid tumors in children and adults, has been reported to cause a variety of reactions in the skin, including erythema, blistering, and hyperpigmentation."3.74Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation. ( Bayliss, SJ; Hayashi, RJ; Lloyd, BM; Rosman, IS, 2008)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosman, IS1
Lloyd, BM1
Hayashi, RJ1
Bayliss, SJ1
Olander, K1
Haik, KG1
Haik, GM1
Harben, DJ1
Cooper, PH1
Rodman, OG1
Horn, TD1
Beveridge, RA1
Egorin, MJ1
Abeloff, MD1
Hood, AF1
Hornblass, A1
Adler, RI1
Vukcevich, WM1
Gombos, GM1
Asregadoo, ER1
Berkow, JW1
Gills, JP1
Wise, JB1
Howitt, D1
Karp, EJ1

Reviews

1 review available for thiotepa and Incontinentia Pigmenti Achromians

ArticleYear
Management of pterygia: should thiotepa be used?
    Annals of ophthalmology, 1978, Volume: 10, Issue:7

    Topics: Animals; Humans; Pigmentation Disorders; Pterygium; Recurrence; Sunlight; Thiotepa

1978

Other Studies

7 other studies available for thiotepa and Incontinentia Pigmenti Achromians

ArticleYear
Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho

2008
Thiotepa-induced leukoderma.
    Archives of dermatology, 1979, Volume: 115, Issue:8

    Topics: Black People; Humans; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Skin; Thiotep

1979
Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation.
    Archives of dermatology, 1989, Volume: 125, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy;

1989
A delayed side effect of topical thiotepa.
    Annals of ophthalmology, 1974, Volume: 6, Issue:11

    Topics: Administration, Topical; Eyelashes; Female; Histocytochemistry; Humans; Melanins; Middle Aged; Pigme

1974
Surgery, thio-tepa, and corticosteroid in the treatment of pterygium.
    American journal of ophthalmology, 1972, Volume: 74, Issue:5

    Topics: Dexamethasone; Follow-Up Studies; Humans; Pigmentation Disorders; Pterygium; Recurrence; Sunlight; T

1972
Depigmentation of eyelids after topically administered thiotepa.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1969, Volume: 82, Issue:3

    Topics: Cornea; Eyelids; Female; Humans; Melanins; Microscopy, Electron; Middle Aged; Photography; Pigmentat

1969
Side-effect of topical Thio-tepa.
    American journal of ophthalmology, 1969, Volume: 68, Issue:3

    Topics: Adult; Eye Diseases; Eyelashes; Humans; Male; Pigmentation Disorders; Pterygium; Thiotepa

1969